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1. INTRODUCTION
Motion sickness (MS) is an ancient problem associated 
with transportation (ships and other vehicles), which is effecting 
humans since ages. MS is a physiological response to the 
conflicts between various senses like optical senses, vestibular 
system and muscular system. These conflicts can lead to 
discomfort and difficulties concentrating and in worst case lead 
to nausea and vomiting1. MS can happen on practically anything 
that under motion. MS is also known as kinetosis and travel 
sickness. MS is a condition in which a disagreement of co-
ordinations exists between visually perceived movement 
and the vestibular system’s senses. The symptoms of MS are 
similar despite the consequences of the stimuli that cause it, 
however they are classified depending on where it occurs such 
as: sea sickness, car sickness, air sickness, space sickness, 
travel sickness and simulator sickness1. About 5 to 10% of 
travellers are highly susceptible to MS, while others show 
moderate susceptibility2. The susceptibility to motion sickness 
varies widely and does not affect all in road transportation3. 
The occurrence of MS, depending on population, Asians are 
more susceptible when compared to others4. The occurrence 
of MS also depending on age and sex; women are experience 
more severe sickness and a higher occurrence of nausea than 
men5. Children less than 2 years old are more vulnerable to 
MS when compared to adults6; and incidents of MS peak 
between 3 and 12 years, and gradually decrease after that7. 
The general responses of autonomic nervous system during 
MS are gastrointestinal and other peripheral changes. It is 
clear that during the process of MS parasympathetic nervous 
system withdrawal and sympathetic nervous system activation 
plays a role. There are several possible relationships that 
were observed between motion sickness susceptibility and 
personality like some physchological disorders such as anxiety, 
claustrophobia and migraine. They are at more risk to MS when 
compared to others8.
2.  TheORIes, meChaNIsms aND 
maNIfesTaTIONs
The human body can receive information about posture 
and movements by various systems such as sensory information 
comes from the inner ear, visual information receives from the 
eyes and prospective information receives from muscles (Fig. 1). 
Although the etiology and precise neurobiological mechanism 
of MS are still in ambiguous. However, several hypotheses 
have been proposed and varieties of countermeasures have 
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been developed to overcome the problems of MS since 
decades. Despite the fact that several hypothesises about the 
pathophysiological mechanisms, neurophysiological process 
and aetiological models of MS are by no means clear. Further, 
there was lack of scientific evidences for several models, 
pathways or the process of adaptation to provocative motion. 
Three main theories exist for motion sickness is as follows9: 
2.1 The sensory Conflict Theory 
This is one of the oldest theory of MS and well accepted 
ones. Sensory conflict theory explains about the elicitation 
of MS to ‘conflicts’ between various sensory organs such as 
between signals from vestibular system and optical senses, 
or signals from canals and otoliths. Furthermore, this theory 
can be called as ‘Neural Mismatch Theory’. The converging 
sensory inputs from the otolith organs, semicircular canals, 
eyes and somatosensory receptors are mismatched with the 
expected sensory patterns in the neural store calibrated by 
past experience, and spatial orientation is disturbed, leading to 
motion sickness. It is unclear whether the brain can compare 
various types of sensory inputs directly, but it seems to be 
capable of creating expectations of motion based on earlier 
experience which is compared with the perceived motion10.
When we are asleep these comparisons do not happen because 
the brain does not analyze the inputs, consequently the sensory 
conflict does not occur and we can accordingly not become 
motion sick11. MS can also occur when an expected stimulus 
does not emerge or when unexpected stimuli emerge as per 
brain comparison1. For example when a person reading in a car 
the vestibular system gives information about movement, but 
the visual system does not confirm this movement and these 
contradictory factors can cause MS12. Norfleet13, et al. have 
experimented sensory conflict theory by rotating the gravity 
vector through 180° (inverted immersion), and created sensory 
conflict between the vestibular signals from semicircular canals 
and visual signals from eyes. They have confirmed sensory 
conflict by inverted immersion must have cause more severe 
motion sickness than upright immersion. Reason14 proposed 
neural mismatch hypothesis based on the reafference principle. 
According to his hypothesis, the situations that provoked 
motion sickness were characterised by a condition of (sensory) 
rearrangement. Further this theory is divided into two types: 
2.1.1  Visual-Vestibular Mismatch Theory
This type of MS always happens on passive means of 
transportation. Mismatch between the senses from vestibular 
organs and the vision. For example, a person is travelling on a 
ship and observing the waves (visual information recognise a 
movement); however, in reality the body does not move. 
2.1.2 Intra-vestibular (Canal-Otolith) Mismatch 
Theory
Sometimes Canal and otolith signals simultaneously give 
contradictory information. For example the vestibular system 
and the muscular system send senses of motion, but the visual 
information do not recognize this. Making head movements 
while rotating in opposite axis of motion or fast head movement 
may lead this type of MS.
2.2 The Poison Theory
Emetic signals received by the coordinated activity of 
both smooth and somatic muscles to induce certain changes 
in intra-abdominal and intra-thoracic pressures, and opening 
of the esophageal sphincters. The poison theory is based on 
genetic responses (old evolutionary programme), where brain 
misreads the neural signals like ‘poison response’ and lead to 
stomach emptying by reflux action to get the poison out of the 
body, as many poisons have the same effects on the body as MS 
does15. The toxin theory is based on the idea that the sensory 
conflicts and postural instability would give us an early sign of 
intake of neurotoxins10. The toxin system works as a backup 
to our other indicators of poisoning such as taste, smell or 
vomiting evoked by effects on the reflexive action on stomach 
or stimulation of the chemoreceptors after absorption. Some 
of the concepts of MS contradict this theory that the toxins 
that have already crossed the blood-brain barrier also have a 
very small biological advantage since the toxins have reached 
the brain cannot be removed by vomiting10. In addition, not 
all motion sickness leads to vomiting which opposes the 
explanation that the key purpose of motion sickness would be 
to remove toxins.
2.3 The Postural Instability Theory
The postural instability theory is not a modification of the 
sensory conflict theory but differs in fundamental ways. Loss 
of stability generally is coupled with a loss of control, such as 
falling down. Postural stability is defined as the condition in 
which uncontrolled movements of the perception and action 
systems are minimised16.  Riccio and Stoffregen16 predicted that 
optical oscillations created by human locomotion should induce 
MS through unintended consequence of exposure to simulations 
of optical flow fields that are created by spontaneous postural 
sway17. Riccio and Stoffregen16 have experimented in animals 
and found that the animals experienced motion sickness due to 
postoral instability. They have suggested that this instability, 
which occurred prior to the onset of the symptoms of motion 
sickness, was a necessary prerequisite of this response. Postural 
instability theory concludes that motion sickness results from 
perceptual-motor anomalies, but not from changes in sensory 
input. According to Riccio and Stoffregen16, MS is caused by 
instability in the control of the posture of the body and/or its 
segments. Therefore, it is defined as rearrangements in the 
relationship between movement and sensorimotor feedback. 
Smart18, et al., reported that postural instability is being the 
onset of symptom after MS and the observations are compatible 
with other theories of motion sickness etiology. 
2.4 The movement Program Theory
The movement program theory is based on that a negative 
and uncomfortable experience of motion other than expected 
would discourage the development of movement programs 
adapted to situations where these vestibular conflicts occurs10. 
The phenomenon is explained as a negative reinforcement 
model, a sort of natural obedience training, to make us stop 
undesirable behaviour and elude the probability of injury. 
The obnoxious sensation of motion sickness is meant to make 
us stop the motion to reduce the feeling, and the vomiting is 
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meant to force us to stop what we are doing since vomiting 
is inconsistent with substantial movement. The effects of the 
negative experience can lead to early avoidance, reduction 
of movement and removal of oneself from the offending 
circumstances10. 
Motion is initiated by the brain through different pathways 
of the nervous system including vestibular system, vision, 
muscular system, etc. The symptoms of motion sickness appear 
when the central nervous system receives conflicting messages 
from the vestibular system, the visual system, sometimes from 
smell and respiratory systems
3. PhysIOlOgy Of mOTION sICKNess
Motion sickness is linked to a pronounced activation 
of the glucocorticoid and sympatico-adrenergic stress 
response systems19. Number of pharmacological agents could 
potentially affect the occurrence of motion sickness through 
their actions in the vestibular nuclei. The cerebral cortex and 
limbic system, particularly the hippocampus, are major sites 
of spatial orientation information processing. A number of 
neurotransmitters influence the activity of vestibular nucleus 
neurons, including acetylcholine, glutamate, glycine, GABA, 
histamine, norepinephrine, dopamine, serotonin, substance 
P, somatostatin, adrenocorticotropic hormone [ACTH] 
and enkephalin20. The histaminergic neuron system in the 
brain has been supposed to play a significant role in the 
pathophysiology of motion sickness. Neural mismatch signals 
activates the histaminergic neuron system in the hypothalamus 
and stimulates H1-receptors of the brainstem, therefore H1-
receptors triggers the development of the symptoms and signs 
of motion sickness, including emesis. 
3.1 The Vestibular system
The vestibular system is exaggerated by vertical and 
horizontal vibrations and forces of acceleration. The vestibular 
system is maintaining the body balance; it records change 
in movement caused by motion and coordinate the position 
of the head through regulation of muscle tension which 
helps us keep our posture. The vestibular system consists of 
semicircular canals and otolith organs1. Calcium carbonate 
crystals present on the otolith organs help us to detect linear 
acceleration and the position of the head. The otoliths are 
responsible for the opposite direction of visual signals when 
the head moves in a roll motion, which is known to be ocular 
counter-rolling21. The part that detects angular acceleration 
is hair cells, called cilia, attached to the inside walls of the 
semicircular canals. The vestibular nuclei receive MS signals 
from the semicircular canals and otolith organs but also visual, 
auditory, somatosensory, and proprioceptively related signals 
and a variety of other afferents including from the cerebellum. 
The indication of angular acceleration tells us that our head is 
moving1. Individuals with a total loss of labyrinthine function 
are not susceptible to motion sickness. 22.
3.2 The Visual system
The visual system is crucial part of the phenomenon of 
MS as it coordinates us to substantiate other organs such as 
vestibular, somatosensory and motor related signals tell us 
to anticipate1. Hence, an optical illusion of movement while 
standing still, or an illusion of non-movement while moving will 
create a conflict between signals to the brain from the optical- 
vestibular system. A conflict can also be created through an optical 
illusion of moving in an opposite direction than the actual. 
4. symPTOms Of mOTION sICKNess
Individual’s response towards MS depends on the 
comparative provocativeness of the stimulation, relative 
susceptibility and previous experience23. Some people on 
receiving provocative stimulation will show a very brief 
response, and others will maintain discomfort for a prolonged 
period. One of the major symptoms of motion sickness is 
vomiting11. Emesis can be triggered by the involvement of a 
variety of peripheral and central afferent mechanisms. The 
causes of vomiting are input from the vestibular apparatus, 
higher brain stem, cortex, gastrointestinal system or viscera24. 
In severe motion sickness with multiple bouts of vomiting, 
alkalosis may develop because of hydrogen ion loss and lead 
to increased renal excretion of potassium bicarbonate resulting 
in potassium deficiency which can cause muscle weakness, 
constipation, and cardiac arrhythmias. The psychological part 
of motion sickness could also trigger vomiting on its own 
since MS signal input triggered from the cerebral cortex to the 
vomiting centre in the brain. The physiology of MS starts with 
provocative motion when travellers exposed initially, therefore, 
it is assumed that MS response would be ‘physiological’ in 
origin. Further, as the people have disagreeable experiences 
with motion then psychological components becomes more 
significant. Therefore, the degrees of MS arousal may vary 
from person to person due their past experiences with a variety 
of different provocative stimuli. 
Physiological motion sickness manifestations are as 
follows: Cardiovascular system includes, Changes in pulse 
rate and/or blood pressure, peripheral circulation decreases 
especially in the skin of the head, tone of arterial portion of 
capillaries in the fingernail bed increases, muscle blood flow 
increases25. During motion sickness respiratory system has 
some manifestation such as, alterations in respiration rate, 
sighing or yawning and air swallowing. In the gastrointestinal 
system the following changes may occur during motion 
sickness, inhibition of gastric intestinal tone and secretions, 
salivation, gas or belching, epigastric discomfort and vomiting. 
Changes in lactic dehyorogen ASE concentrations in the body 
fluids are one manifestation studied under motion sickness. 
Blood and urine of the patients have several changes like, 
increased haemoglobin concentration, decreased concentration 
of eosenophils and glucose utilisation, higher levels plasma 
protein and ADH. Both blood and urine have increased levels of 
17-hydroxycorticosteroids and of catacolamines during motion 
sickness. Visual system has some adverse manifestations like 
ocular imbalance, dilated pupils during emesis, small pupils 
and nystagmus.
Serious symptoms of MS include: nausea, vomiting, 
pallor, sweating, drooling, short breath, dizziness, drowsiness; 
other common signs are: a general feeling of discomfort and 
not feeling well (malaise); mild symptoms are categorised as: 
headache, mild unease and yawning. 
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5. PReDICTION aND eValUaTION Of ms
It has been established that almost all travellers can 
obtain MS when exposed to appropriate provocative motion. 
MS incidence is depended on individual threshold to motion 
stimulation and varies under various vertical motion parameters 
such as acceleration magnitude, frequency, and duration26. 
Some of the researchers have made some calculation to predict 
sea sickness named it as ‘sicken passengers ration’, which 
includes ship speed, loading condition, sea state, passenger 
behavior and habituation to moving environment27. These 
calculations may improve the degree of comfort and the 
work ability on the sea.MS can be diagnosed according to 
the manifestations during motion exposure after excluding 
other pathological disorders. Heart rate variability (HRV) can 
be useful for assessing cardiac sympathovagal interactions 
and electrogastrogram (EGG) would be useful to find gastric 
motility during MS.
6. PReVeNTINg mOTION sICKNess
Prevention of motion sickness can be complex. A small 
percentage of normal individuals are highly susceptible for 
nearly all exposure situations, a small percentage are highly 
insusceptible, and most are in between. The best prevention 
for the highly susceptible is avoidance. For other individuals, 
spaced exposure of short duration can lead to a buildup of 
adaptation to the provocative situation. This is especially 
effective if only minor symptoms of motion sickness are 
allowed to develop before terminating each exposure period. 
Alternatively, incremental exposure to gradually increasing 
levels of provocative stimulation (e.g., making head movements 
during exposure to passive body rotation at higher and higher 
rotation velocities) can allow adaptation to be achieved without 
motion sickness being elicited even at stressor levels that if 
achieved in a single step would be intolerably provocative. 
Some of the classes of drugs which have been used to 
treat motion sickness are given below. Medications are most 
effective when taken prophylactically before traveling, or 
as soon as possible after the onset of symp toms. Common 
side effects of these medications are dry eyes, dry mouth, 
sensitivity to bright light; Less common side effects are blurred 
vision, dizziness, headache, sedation. A list of pharmacological 
approaches haven been given in Table 1.
Table 1. Pharmacological countermeasures for motion sickness
Category Name of drug Dosage & route of application Usage References
antihistamines
Dimenhydrinate
p.o. (100 mg) 2 h before travel 45
Chewing gum (3 X 20 mg) Chewed for 30 min each during travel 28
Cinnarizine Oral (30 or 50 mg) 3 h before travel 29
Cyclizine (Marezine) p.o. (50 mg) 2 h before travel 44
Promethazine
p.o. ( 25 or 50 mg 2 h before travel 46
i.m. (25 or 50 mg) 1–2 h before travel 30
Suppository (25 or 50 mg 1–2 h before travel 31
Meclizine (Antivert) p.o. (25 or 50 mg) 1–2 h before travel 47
Chlorpheniramine, p.o. (4 or 12 mg) 3–4 h before travel 32 
Betahistine p.o. (32 or 48 mg) 1–2 h before travel 33
Dopamine 
antagonists Metoclopramide i.v. (20 mg) 15 min after travel initiation 48
anticholinergics Scopolamine
p.o. (0.6 mg) 0.5–1 h before travel 43
Transdermal therapeutic system 
(1.5 mg/patch) 6–8 h before travel 43
Intranasal (0.4 mg) 0.5 h before travel 34
p.o. (0.3 mg) + TTS 1 h before travel 35
hormones Dexamethasone i.v. (0.5 mg) Every 6 h for 48 h 36
5-hT1B/1D 
receptor agonist Rizatriptan p.o. (10 mg) 2 h before travel 37
Combination
Promethazine +
d-amphetamine p.o. (25 mg+10 mg) 2 h before travel 38
Scopolamine +
d-amphetamine p.o. (0.4–1.2 mg+5 mg) 0.5–1 h before travel 39
Scopolamine +
ephedrine
p.o. (0.3 mg+25 mg)
i.m. (0.2 mg+25 mg)
0.5–1 h before travel or 3 times daily
30 min before travel 40-41
Chlorpheniramine +
Ephedrine p.o. (12 mg+50 mg) 3–4 h travel 42
p.o : Per oral; i.v ; intravenous; i.m. intramuscular
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6.1 Benzodiazepines
Benzodiazepines are occasionally adminis tered for severe 
symptoms of motion sickness. The serotonin antagonist ondan-
setron (Zofran) is ineffective for the preven tion and treatment 
of motion sickness.
6.2 anticholinergics 
Scopolamine, an anticholinergic, is a first-line option for 
preventing motion sickness in persons who wish to maintain 
wakefulness during travel. Transdermal patches are most 
effective, one patch applied to mastoid at least four hours before 
travel, then every 72 hours as needed. If the recommended dose 
of scopol amine does not adequately relieve symptoms, the dose 
may be doubled. Oral scopolamine treatment is moderately 
effective, 0.4 to 0.6 mg one hour before travel, then every eight 
hours as needed43. 
6.3 antihistamines 
First-generation antihistamines have been used to treat 
motion sickness since the 1940s. Antihistamines are H1-
antagonists have been successfully demonstrated to be efficient 
in controlling motion sickness. As histaminergic neuron 
system is involved in the symptomatic mechanism of MS via 
H1-receptors, this group of medicines can reduce the severity 
of the symptoms and signs of motion sickness by blocking the 
emetic linkage. They are generally recommended for patients 
who can tolerate their sedative effects. Cyclizine (Marezine)44, 
dimenhydrinate45, pro methazine46, and meclizine47 (Antivert) 
demonstrated effectiveness. Nonsedating antihistamines are 
not effective in preventing or treating motion sickness.
6.4 monoamine antagonists/agonist
Dopamine D2 and D3 receptors are known to play a role 
in nausea and emesis. They can alter the amount of cAMP 
within neurons of the vomiting center via inhibiting the CTZ 
in the area postrema. Dopamine D2-receptor antagonists such 
as domperidone and metochropramide are clinically used as 
anti-emetic drugs48.
6.5 Traditional medicinal systems  
Various Indian medicinal plants are also reported for 
their effective use in the treatment of emesis. Furthermore, 
several Ayurvedic system of medicine and traditional Chinese 
Medicine (TCM) consists of number of natural products used in 
the treatment of emesis. Asian herbs such as Agastache rugosa; 
leaves of Mentha piperita; flowers of Eriobotrya japonica and 
Eugenia caryophyllata; fruits of Cocos nucifera and Amomum 
cardamomum; roots of Cyperus rotundus; rhizome of Zingiber 
officinale are generally used to treat emesis47-50.
• ginger: Ginger is one of the most effective home 
remedies for motion sickness. For nausea, ginger extract 
works very well. One can have this extract along with a 
tea spoon of honey or keeping a slice of ginger in mouth 
while travelling also proves effective to cope with travel 
sickness51.
• Peppermint:  Peppermint also proves to be effective 
in dealing with motion sickness. Prepare and drink a 
peppermint tea before your travel52.
• lemon: The smell of lemon gives relief when one feels 
nauseated. It is better to keep a lemon and keep inhaling 
the smell while travelling. Drinking a glass of lemon 
water also works well53. 
• fennel (Foeniculum vulgare) is another herb that can be 
used to prevent and treat motion sickness51.
• marjoram, Rosemary and Basil are other herbs that 
work for them against motion sickness53. 
7.  BehaVIORal sTRaTegIes TO PReVeNT 
OR mINImIse symPTOms Of mOTION 
sICKNess 
 The most effective remedial measure, at least in the 
long term, is adaptation to the provoking motion, and it is 
the ideal method of minimize motion sickness. Prevention of 
motion sickness is more effec tive than treating symptoms after 
they have occurred. Therefore, patients should learn to identify 
situations that may lead to motion sickness and be able to initiate 
behavioural strategies to prevent or minimise symp toms. With 
continuous exposure to motion, symp toms of motion sickness 
will usually subside in one to two days. Alternatively, slow, 
inter mittent habituation to motion is an effective strategy to 
reduce symptoms. It is important to note that multiple and off-
axis motions are worse than one-axis motions; low-frequency 
motions are worse than high-frequency motions; rotary 
motion is worse than linear motion and the vertical motions 
are worse than horizontal motions. Adaptation is one of the 
most effective techniques to overcome MS. A stimulus with a 
gradual onset generates fewer symptoms and allows for more 
rapid adaptation than a stimulus with an abrupt onset. under the 
adaptation of MS the following two techniques may be useful 
such as, sensory adaptation-decreasing response following 
continuous stimulation of a receptor system, and protective 
adaptation-adaptation to a sensory mismatch signals. Golding54 
prepared a factor analysis of self-report questionnaires, which 
is designed to assess susceptibility MS, this questionnaire 
may help in getting information with respect to the existence 
of independent latent susceptibilities to different types of 
provocative environments, usually forming factors that might 
be termed transportation by land, air or sea (Appendix ‘A‘).
8.  DIReCTIONs fOR PReVeNTIVe measURes 
fOR mOTION sICKNess
The important directions include sitting in a position so 
that the eyes can see the same motion that the body and inner ear 
feels, sitting in the front seat and looking at the distant scenery 
if in a car, going up on the deck and watching the motion 
of the horizon if on a boat, sitting by the window and look 
outside in an airplane, choosing a seat over the wings where 
the motion is minimised, avoiding  reading while travelling, 
avoiding sitting in a seat facing backward, avoiding watching 
or talking to another traveller who is having motion sickness, 
avoiding strong odors and spicy or greasy foods immediately 
before and during travel, avoiding excessive alcohol and 
smoking and foods or liquids that make feel unusually full, 
adapting breathing techniques (as slow and deep breaths lead 
to comparatively fewer symptoms), chewing a gum to maintain 
balance between vision and balance, eating a bland food such 
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as pancakes or a bagel or eating banana, rice, apple and toast 
(BRAT) diet, avoiding acidic food and drinks, etc. Sleeping 
has a helpful on MS symptoms as it reduces the excitability of 
the vestibular system and thus reduces the sensory conflict.
9.  CONClUsION
This paper reviews the signs and symptoms, stimuli and 
response characteristics, anatomical structures, susceptibility 
factors, and theories of motion sickness. It is evident from 
this review that motion sickness is both polysymptomatic 
and polygenic and traditional way of tackling by dietary 
therapy might also play a vital role. More systematic research 
using animal model, the toxicological studies of the herbal 
formulations and the structured human trials are warranted to 
provide an insight into the problem of seasickness. 
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Do you have any of the following symptoms right now ? (tick 
boxes)
s. No. None slight moderate severe
1 General discomfort
2 Fatigue
3 Headache
4 Eye strain
5 Difficulty focusing
6 Increased salivation
7 Sweating
8 Nausea
9 Difficulty concentrating
10 Fullness of head
11 Blurred vision
12 Dizziness (eyes open)
13 Dizziness (eyes closed)*
14 Vertigo
15 Stomach awareness
16 Burping
Table 2. symptom questionnaire for motion sickness including illusory feelings of motion (golding, 1998)
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